Homocysteine and Asymmetric Dimethylarginine (ADMA) in Neurological Diseases
Journal Title: JOURNAL OF ADVANCES IN CHEMISTRY - Year 2014, Vol 6, Issue 2
Abstract
Homocysteine (Hcy) is formed from methionine (Met) and is distributed in two metabolic pathways: in the process of remethylation to Met and in the process of transsulfuration to cysteine. Hyperhomocysteinemia (HHcy) is a risk factor for cardiovascular and neurological diseases such as: Alzheimer’s and Parkinson’s diseases, multiple sclerosis, and stroke. Increased Hcy level may lead to endothelial dysfunction due to impaired bioavailability of endothelium-derived nitric oxide (NO). The molecular mechanism decreasing the levels of NO in HHcy conditions is incompletely understood, but it seems that asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NO synthase, may be a key factor. ADMA is formed from L-arginine by enzymes in the family of protein N-methyltransferases (PRMT) and may undergo hydrolysis to L-citrulline and dimethylamine with the participation of dimethylaminohydrolase (DDAH). In pathological conditions such as neurodegenerative diseases, Hcy may lead to increased ADMA concentrations by inhibiting the activity of DDAH. Several drugs, such L-dopa, antiepileptic drugs, and lipid-lowering drugs, may interfere with the metabolic pathways of thiols, leading to an alteration of plasma Hcy and ADMA levels. It seems that administration of L-arginine, in conjunction with B vitamins, to patients with HHcy may be a new method in the treatment of neurodegenerative diseases.
Authors and Affiliations
Jolanta Dorszewska
Predication of Drug Target Interaction using Reliable Multicast Routing in Wireless Ad hoc Molecular Network
Wireless Ad hoc Molecular network consists of atoms in terms of nodes in the absence of administrative point. In this connection, there is a need to adopt molecular analogy to define the architecture. Prediction of Drug...
Synthesis and studies of complex compounds of carboxyl-derivatives of methylphloroglucinol with metals
Ten new complexes of 2,4,6–trihydroxy-3-methyl benzoic acid (methylphloroglucinol, L1) and 2,4,6–trihydroxy benzoic acid (phloroglucinol, L2) are isolated in the solid state, and their formulae were detected.The spec...
Synthesis, anti-inflammatory and molecular docking of some new 1,2,4-triazolobenzimidazol-3-yl acetone thiosemicarbazone cyclized derivatives as PLA-2 inhibitors
The present work is carried out for the synthesis and evaluation of some new 1,3,4-thiadiazolines, 1,3-thiazolines and 1,3-thiazolidin-4-ones linked to 1,2,4-triazolo[1,5-a]benzimidazole as anti-inflammatory agents. Stru...
Secondary Metabolites from the Leaves of Aquilaria agallocha
Twelve compounds, including three flavonoids, 5-hydroxy-4¢,7- dimethoxyflavone (1) [22], luteolin-7,3¢,4¢-trimethyl ether (2) and 5,3¢- dihydroxy-7,4¢-dimethoxyflavone (3), five benzenoids, methylparaben (4), vanill...
Corrosion Monitoring of Sabic Iron in Hydrochloric Acid Solutions using some Azo Compounds – Molecular Dynamics, Chemical and Electrochemical Studies
The corrosion inhibition behaviour of Sabic iron in the absence and in presence of some azo compounds derived from 2, 3-and 2, 7-dihydroxynaphthalene was investigated using weight loss, thermometry and galvanostatic pola...